EUROBIO-SCIENTIFIC (EPA:ALERS) Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
Transparency directive : regulatory news
19/12/2024 10:30
source : webdisclosure.com